Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥7.7b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.8b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

China Traditional Chinese Medicine Holdings

Market Cap: HK$11.6b

China Traditional Chinese Medicine Holdings Co.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥32.5b

Asymchem Laboratories (Tianjin) Co., Ltd.

PharmaResearch

Market Cap: ₩4.2t

Operates as a biopharmaceutical company primarily in South Korea.

Sumitomo Pharma

Market Cap: JP¥969.8b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Jazz Pharmaceuticals

Market Cap: Mex$10.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Maccura BiotechnologyLtd

Market Cap: CN¥6.9b

Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$6.4b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥11.9b

Engages in the blood product businesses in China.

Nanjing Vazyme Biotech

Market Cap: CN¥8.7b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

Pulike Biological Engineering

Market Cap: CN¥4.5b

Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.

CanSino Biologics

Market Cap: HK$13.4b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Telix Pharmaceuticals

Market Cap: AU$5.0b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

HUTCHMED (China)

Market Cap: HK$1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Seegene

Market Cap: ₩1.2t

Manufactures and sells molecular diagnostics products worldwide.

Chongqing Taiji Industry(Group)Ltd

Market Cap: CN¥10.6b

Produces, and sells Chinese and western medicine products in China and internationally.

BeOne Medicines

Market Cap: CN¥36.7b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$6.4b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.4b

Produces and sells medicines in China.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥8.0b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

Bora Pharmaceuticals

Market Cap: NT$65.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥8.7b

Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.

Shanghai Runda Medical Technology

Market Cap: CN¥9.1b

Shanghai Runda Medical Technology Co., Ltd.

DongKook Pharmaceutical

Market Cap: ₩838.9b

Produces and sells pharmaceutical products in South Korea and internationally.

AbbVie

Market Cap: €404.2b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

HUTCHMED (China)

Market Cap: UK£1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Beximco Pharmaceuticals

Market Cap: UK£49.2b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Camurus

Market Cap: SEK 36.0b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Oxford Biomedica

Market Cap: UK£746.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Merck KGaA

Market Cap: €52.5b

Operates as a science and technology company in Germany and internationally.

GSK

Market Cap: UK£72.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Dynavax Technologies

Market Cap: US$1.3b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Merck KGaA

Market Cap: US$52.5b

Operates as a science and technology company in Germany and internationally.

Pharming Group

Market Cap: US$966.1m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Otsuka Holdings

Market Cap: US$4.8t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.